Condition
Volunteer
Total Trials
6
Recruiting
2
Active
2
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Completed4
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07232121Phase 1Recruiting
A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults
NCT07279233Phase 1Completed
To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
NCT07354607Not ApplicableRecruitingPrimary
Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow
NCT07447310Not ApplicableCompleted
Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health
NCT01517087Completed
Studying Motor Neuron Tests
NCT00397748CompletedPrimary
PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Showing all 6 trials